<DOC>
	<DOCNO>NCT02589678</DOCNO>
	<brief_summary>Participants receive vaccination measles , mumps , rubella ( MMR ) tetanus , diphtheria , pertussis , inactivate polio ( Tdap-IPV ) . The study schedule design simulate vaccine efficacy trial see single woman participate study mimic actual HIV vaccine study .</brief_summary>
	<brief_title>Zambia SiVET MMR Tdap-IPV</brief_title>
	<detailed_description>This study evaluate woman high risk HIV infection reside Lusaka , Zambia Ndola , Zambia willing participate retain future HIV vaccine trial . 150 woman enrol either sex worker single woman identify infant vaccination clinic ( risk due recent pregnancy indicate unprotected sexual contact outside marriage cohabitation ) . Two licensed vaccine administer proxy HIV vaccine administration . The clinic laboratory procedure simulate HIV vaccine trial procedure therefore inform recruitment retention strategy HIV incidence among high risk woman future HIV vaccine trial .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At high risk HIV , define occupation ( female sex worker ) recent delivery ( single mother ) Planning stay Lusaka Ndola least 12 month Willing undergo HIV testing , counsel receive HIV test result Able willing provide adequate locator information tracking purpose , willing contact study staff Willing able provide adequate locator information willing contact phone available home visit study staff . Willing answer question HIV risk factor , infect , question relate route timing exposure Willing able return followup visit Willing able provide inform consent Willing undergo pregnancy test use injectable , implant intrauterine device ( IUD ) screen four month last vaccination study HIV1/2 infection Pregnant intend become pregnant study History severe allergic reaction substance include egg , gelatin , neomycin Any clinically significant acute illness chronic medical condition consider progressive , opinion investigator , make volunteer unsuitable participation study Immunosuppressive therapy Women opt HIV counsel test service provide clinic Women condition opinion Investigator designee , would preclude provision inform consent , otherwise interfere achieve study objective Participation another clinical trial unless approve Principal Investigator International AIDS Vaccine Initiative ( IAVI ) Recent receipt investigational blood product vaccine Failure assessment understanding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>AIDS</keyword>
	<keyword>Immunology</keyword>
	<keyword>Public Health</keyword>
	<keyword>Female sex worker</keyword>
	<keyword>Single mother</keyword>
</DOC>